293 related articles for article (PubMed ID: 27138094)
1. Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis.
Haas J; Schwarz A; Korporal-Kuhnke M; Faller S; Jarius S; Wildemann B
J Neuroimmunol; 2016 May; 294():18-26. PubMed ID: 27138094
[TBL] [Abstract][Full Text] [Related]
2. Effects of Vitamin D and Dexamethasone on Lymphocyte Proportions and Their Associations With Serum Concentrations of 25-Hydroxyvitamin D
Cho EB; Shin JH; Kwon S; Kim J; Seok JM; Kim BJ; Min JH
Front Immunol; 2021; 12():677041. PubMed ID: 34394078
[TBL] [Abstract][Full Text] [Related]
3. B cells undergo unique compartmentalized redistribution in multiple sclerosis.
Haas J; Bekeredjian-Ding I; Milkova M; Balint B; Schwarz A; Korporal M; Jarius S; Fritz B; Lorenz HM; Wildemann B
J Autoimmun; 2011 Dec; 37(4):289-99. PubMed ID: 21924866
[TBL] [Abstract][Full Text] [Related]
4. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
Bar-Or A; Fawaz L; Fan B; Darlington PJ; Rieger A; Ghorayeb C; Calabresi PA; Waubant E; Hauser SL; Zhang J; Smith CH
Ann Neurol; 2010 Apr; 67(4):452-61. PubMed ID: 20437580
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of Vitamin D in multiple sclerosis.
Correale J; Ysrraelit MC; Gaitán MI
Brain; 2009 May; 132(Pt 5):1146-60. PubMed ID: 19321461
[TBL] [Abstract][Full Text] [Related]
6. Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis.
Knippenberg S; Smolders J; Thewissen M; Peelen E; Tervaert JW; Hupperts R; Damoiseaux J
Mult Scler; 2011 Dec; 17(12):1418-23. PubMed ID: 21690147
[TBL] [Abstract][Full Text] [Related]
7. GM-CSF production by CD4+ T cells in MS patients: regulation by regulatory T cells and vitamin D.
Peelen E; Muris AH; Damoiseaux J; Knippenberg S; Broens K; Smolders J; Cohen Tervaert JW; Hupperts R; Thewissen M
J Neuroimmunol; 2015 Mar; 280():36-42. PubMed ID: 25773153
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis: Vitamin D deficiency leads to excessive B-cell responses in multiple sclerosis.
Fyfe I
Nat Rev Neurol; 2016 May; 12(5):252. PubMed ID: 27063105
[No Abstract] [Full Text] [Related]
9. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
Hiremath GS; Cettomai D; Baynes M; Ratchford JN; Newsome S; Harrison D; Kerr D; Greenberg BM; Calabresi PA
Mult Scler; 2009 Jun; 15(6):735-40. PubMed ID: 19383644
[TBL] [Abstract][Full Text] [Related]
10. Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil.
Becker J; Callegaro D; Lana-Peixoto MA; Talim N; Vidaletti T; de Paula Corrêa M; Gomes I
J Neurol Sci; 2016 Apr; 363():236-9. PubMed ID: 27000256
[TBL] [Abstract][Full Text] [Related]
11. Immune regulatory effects of high dose vitamin D
Muris AH; Smolders J; Rolf L; Thewissen M; Hupperts R; Damoiseaux J;
J Neuroimmunol; 2016 Nov; 300():47-56. PubMed ID: 27806875
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
Faridar A; Eskandari G; Sahraian MA; Minagar A; Azimi A
Acta Neurol Belg; 2012 Dec; 112(4):327-33. PubMed ID: 22767049
[TBL] [Abstract][Full Text] [Related]
13. Age-Associated B Cells with Proinflammatory Characteristics Are Expanded in a Proportion of Multiple Sclerosis Patients.
Claes N; Fraussen J; Vanheusden M; Hellings N; Stinissen P; Van Wijmeersch B; Hupperts R; Somers V
J Immunol; 2016 Dec; 197(12):4576-4583. PubMed ID: 27837111
[TBL] [Abstract][Full Text] [Related]
14. Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.
Piccio L; Naismith RT; Trinkaus K; Klein RS; Parks BJ; Lyons JA; Cross AH
Arch Neurol; 2010 Jun; 67(6):707-14. PubMed ID: 20558389
[TBL] [Abstract][Full Text] [Related]
15. Association of vitamin D status with multiple sclerosis in a case-control study from Morocco.
Skalli A; Ait Ben Haddou EH; El Jaoudi R; Razine R; Mpandzou GA; Tibar H; El Fahime E; Bouslam N; Alami A; Benomar A; Hajjout K; Yahyaoui M; Bouhouche A
Rev Neurol (Paris); 2018 Mar; 174(3):150-156. PubMed ID: 29525037
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
Wurth S; Kuenz B; Bsteh G; Ehling R; Di Pauli F; Hegen H; Auer M; Gredler V; Deisenhammer F; Reindl M; Berger T
PLoS One; 2017; 12(8):e0182462. PubMed ID: 28777826
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid.
Vrethem M; Mattsson E; Hebelka H; Leerbeck K; Osterberg A; Landtblom AM; Balla B; Nilsson H; Hultgren M; Brattström L; Kågedal B
Mult Scler; 2003 Jun; 9(3):239-45. PubMed ID: 12814169
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal levels of vitamin D and IgG in multiple sclerosis.
Holmøy T; Lossius A; Gundersen TE; Moen SM; Castellazzi M; Fainardi E; Casetta I
Acta Neurol Scand; 2012 Jun; 125(6):e28-31. PubMed ID: 21781056
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.
Martinelli V; Dalla Costa G; Colombo B; Dalla Libera D; Rubinacci A; Filippi M; Furlan R; Comi G
Mult Scler; 2014 Feb; 20(2):147-55. PubMed ID: 23836877
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta.
Åivo J; Hänninen A; Ilonen J; Soilu-Hänninen M
J Neuroimmunol; 2015 Mar; 280():12-5. PubMed ID: 25773149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
